BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 18, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Jan. 20, 2026

Jan. 20, 2026
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Immunitybio, Saofi.
Read More

In the clinic for Jan. 20, 2026

Jan. 20, 2026
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amplia Therapeutics, Immunofoco Biotechnology, Lynk Pharmaceuticals, Teva Pharmaceutical Industries.
Read More

Other news to note for Jan. 20, 2026

Jan. 20, 2026
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Applied Cells, AFT, Beyond Air, Combinableai, Eisai, Elpasbio, Formosa, Fosun Kairos, Immuneel, Insitro, LG Chem, Neuronos, Novartis, Nuvation, Pacira Biosciences, Samil, SL Bio, Stablepharma, XLT Biopharmaceuticals, Zonsen Peplib Biotech.
Read More

Financings for Jan. 20, 2026

Jan. 20, 2026
Biopharmas in Asia-Pacific raising money in public or private financings: Biofrontera, Ferrer, Hatchtech, Pelthos, Qurient, Vibrant.
Read More

Regulatory actions for Jan. 16, 2026

Jan. 16, 2026
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Adolore, Eli Lilly, Sanofi, Santhera.
Read More

Other news to note for Jan. 16, 2026

Jan. 16, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Agenus, AFT, Alfasigma, Alveus, Eagle, Innovative Molecules, LXO, Stablepharma, Zydus.
Read More

In the clinic for Jan. 16, 2026

Jan. 16, 2026
Clinical updates, including data readouts and publications: Gradalis, HMNC, J&J, Medicenna, Neurocrine, Ocugen, OS Therapies, Teva, Vaxart.
Read More

Financings for Jan. 16, 2026

Jan. 16, 2026
Biopharmas raising money in public or private financings, including: Bridgebio, Qurient.
Read More

Appointments and advancements for Jan. 16, 2026

Jan. 16, 2026
New hires and promotions in the biopharma industry, including: Flashpoint, Viromissile.
Read More

Appointments and advancements for Jan. 16, 2026

Jan. 16, 2026
New hires and promotions in the med-tech industry, including: Bioretec.
Read More
Previous 1 2 … 82 83 84 85 86 87 88 89 90 … 1823 1824 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • Illustration of T cells attacking cancer

    GABA signaling linked to immune resistance in some tumors

    BioWorld
    Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing